Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors
Introduction
Vascular aging is associated with a decrease in endothelial dilatory and antithrombotic functions (Cooper et al., 1994, Lakatta, 2002, Donato et al., 2007). This typical endothelial dysfunction, however, is also present in younger patients with cardiovascular diseases (CVD) (Cohen, 1995). At the cellular level, aging of healthy vascular endothelial cells (EC) leads to senescence, a state of permanent growth arrest in which cells remain alive and metabolically active for months but refractory to mitogenic stimuli (Ben-Porath and Weinberg, 2005, Chen and Goligorsky, 2006). Senescence can be triggered by cell divisions, leading to cumulative telomere attrition down to a threshold length at which cells enter the so-called replicative senescence (Allsopp et al., 1995). In healthy humans, telomere shortening is age-dependent (Slagboom et al., 1994, Chang and Harley, 1995, Brouilette et al., 2007) and likely the consequence of life-long reparative cell divisions. Telomere length has been proposed to contribute and to be a predictor of mortality in many aged-related diseases (Cawthon et al., 2003). Cellular senescence can occur prematurely, independent of replicative age, following exposure to multiple types of stress (stress-induced senescence), such as oxidative stress (Toussaint et al., 2000), DNA damage and mitogenic stress (Ben-Porath and Weinberg, 2005).
Senescence is characterized by specific changes in cell morphology and gene expression, which reduce EC function (Benetos et al., 2001, Wagner et al., 2001) and thus are proposed to be pro-atherogenic (Cohen, 1995, Serrano and Andres, 2004, Edo and Andres, 2005). Although mitotically inactive, senescent cells are not physiologically inert: they secrete degradative enzymes, inflammatory cytokines and growth factors (Chen and Goligorsky, 2006) and this could promote or contribute to the pathogenesis of human atherosclerosis (Minamino and Komuro, 2007). While the concept of senescence of EC is established, its origin is debated. Life-long cell repairs likely promotes instability and one consequence is an imbalance in the regulation of the redox environment towards pro-oxidation, a process accelerated by risk factors for CVD (Csiszar et al., 2002). The ensuing oxidative stress induces cellular damage (Lorenz et al., 2001, von Zglinicki et al., 2005) and further accelerates reparative cell division, promoting telomere instability (Kurz et al., 2004). Excessive telomere shortening in circulating white blood cells has been reported from patients with hypertension (Jeanclos et al., 2000), coronary atherosclerosis (Samani et al., 2001, Fitzpatrick et al., 2007, Brouilette et al., 2007), premature myocardial infarction (Brouilette et al., 2003), heart disease (Starr et al., 2007) and diabetes (Jeanclos et al., 1998). There is therefore a strong rationale for the hypothesis that risk factors for CVD accelerate the normal aging process as recently proposed by Chen and Goligorsky (2006). It is not known, however, if the association of short telomere length with the risk of coronary heart disease applies to other cell types, especially vascular tissue. The telomere-independent caveolin/p53 pathway has been reported to be activated by oxidative stress and lead to senescence (Galbiati et al., 2001, Volonte et al., 2002). In replicative senescence, however, telomere attrition following activation of ATM/p53-p21 pathway has been observed (Pandita, 2002, Herbig et al., 2004, Herbig and Sedivy, 2006).
The objective of the present study was therefore to elucidate the impact of chronic exposure to risk factors for CVD on the senescence of EC isolated and cultured from patients with severe coronary artery disease (CAD) and to find the pathway of choice leading to senescence. We demonstrate that the duration of exposure to risk factors for CVD, especially hypertension, positively correlates with the propensity of EC senescence, independent of the age of the donor. Thus, stress associated cell damages accelerated replicative senescence.
Section snippets
Clinical profile of the donors
Segments of human distal (close to the bifurcation) internal mammary artery (IMA, Table 1) discarded during primary CABG were harvested with low electrocautery energy and excised with cold scissors. The protocol has been approved by our institutional ethical committee.
Isolation and culture of EC
Endothelial cells were isolated by an explant technique (Shi et al., 2000, Thorin et al., 1997). Briefly, six to eight 1-mm2 segments of mammary artery were seeded in 35-mm2 culture dishes to obtain five to eight segments anchored
Senescence in endothelial cells from patients with coronary artery disease
Cell cultures were characterized by immunostaining for the von Willebrand factor and CD31. Senescence was induced in vitro by serial passage, and cells were positive for the specific endothelial markers whether or not they were senescent (Fig. 1A–D). Senescent EC exhibited phenotypic changes: cytoplasmic size was increased up to 20 times, associated with the inclusion of vacuoles and positive staining for senescence-associated β-galactosidase at pH 6 (Fig. 1E and F).
SA-beta-Gal staining was
Discussion
The literature suggests that risk factors for CVD accelerate the normal aging process of the endothelium (Cooper et al., 1994, Cohen, 1995, Lakatta, 2002, Edo and Andres, 2005, Chen and Goligorsky, 2006). Our study shows that senescence of EC from atherosclerotic patients is characterized by low EC growth potential, specific changes in cell phenotype, gene and protein expression and telomere shortening independent of the age of the donor. The duration of exposure to risk factors for CVD,
Acknowledgements
This work has been supported in part by the Foundation of the Montreal Heart Institute, the Heart and Stroke Foundation of Quebec, and the Canadian Institute for Health Research (MOP 14496). Guillaume Voghel is a fellow of the Fonds de la Recherche en Santé du Québec. We thank Guy Charron (Montreal Heart Institute) for fruitful discussions and technical advises, and the biological tissue bank (RETEB) of the Fonds de la Recherche en Santé du Québec for technical support.
References (53)
- et al.
The signals and pathways activating cellular senescence
Int. J. Biochem. Cell Biol.
(2005) - et al.
Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland primary prevention study: a nested case–control study
Lancet
(2007) - et al.
Association between telomere length in blood and mortality ion people aged 60 years or older
Lancet
(2003) - et al.
Caveolin-1 as a prime modulator of aging: a new modality for phenotypic restoration?
Mech. Ageing Dev.
(2005) - et al.
Senescent phenotype can be reversed by reduction of caveolin status
J. Biol. Chem.
(2003) The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease
Prog. Cardiovasc. Dis.
(1995)- et al.
Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53 and p21CIP1, but not p16INK4a
Mol. Cell
(2004) - et al.
Regulation of growth arrest in senescence: telomere damage is not the end of the story
Mech. Ageing Dev.
(2006) - et al.
Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease
J. Surg. Res.
(2005) - et al.
BJ fibroblasts display high antioxidant capacity and slow telomere shortening independent of hTERT transfection
Free Radic. Biol. Med.
(2001)
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Cell
Telomere shortening in atherosclerosis
Lancet
Microarray analysis of replicative senescence
Curr. Biol.
Association between telomere length and heart disease in a narrow age cohort of older people
Exp. Gerontol.
Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes
Exp. Gerontol.
Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis
Exp. Gerontol.
Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema
Chest
Loss of chromosome 13 in cultured human vascular endothelial cells
Exp. Cell Res.
Telomere shortening in associated with cell division in vitro and in vivo
Exp. Cell Res.
Short telomeres are associated with increased carotid atherosclerotis in hypertensive patients
Hypertension
Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity
Hypertension
White cell telomere length and risk of premature myocardial infarction
Arterioscler. Thromb. Vasc. Biol.
Telomere length and replicative aging in human vascular tissues
Proc. Natl. Acad. Sci. U.S.A.
Premature senescence of endothelial cells: Methusaleh's dilemma
Am. J. Physiol.
The vasculopathy of ageing
J. Gerontol.
Ageing-induced phenotypic changes and oxidative stress impair coronary arteriolar function
Circ. Res.
Cited by (125)
Understanding the intricacies of cellular senescence in atherosclerosis: Mechanisms and therapeutic implications
2024, Ageing Research ReviewsEndothelial cell senescence — understanding aging and disease
2023, Current Opinion in PhysiologyThe Quest for a Biomarker of Premature Biological Aging
2022, Canadian Journal of CardiologyTargeting senescent cells to attenuate cardiovascular disease progression
2020, Ageing Research ReviewsPharmacological inhibition of guanosine triphosphate cyclohydrolase1 elevates tyrosine phosphorylation of caveolin1 and cellular senescence
2019, European Journal of PharmacologyCitation Excerpt :Caveolin1 is implicated in numerous cellular processes, including cell cycle regulation, cellular-senescence, apoptotic signalling and tissue reparative processes (Kurzchalia et al., 1992; Gvaramia et al., 2013; Cho et al., 2004; Ohno-Iwashita et al., 2010; Wheaton, 2011). Several evidences have demonstrated that caveolin1 has a critical role in premature senescence (Yu et al., 2017; Zou et al., 2011; Voghel et al., 2007) as it mediates apoptosis through its expression and post-translational-modification (PTM). OS is known to promote pY14 via p38-MAPK activation (Huot et al., 1996; Bellomo and Mirabelli, 1992), which in turn mediates apoptosis (Bulavin et al., 1999; Huang et al., 1999).
Effects of Cadmium Exposure on Oxidative Stress in Atherosclerotic Rats by Downregulating TopBP1 Expression to Induce Mitochondrial DNA Damage
2024, Alternative Therapies in Health and Medicine
- 1
These authors equally contributed to this work.